HBM Healthcare Investments AG logo

HBM Healthcare Investments AG (0QOC)

Market Closed
12 Dec, 15:30
LSE LSE
215. 50
CHF
+5.5
+2.62%
CHF
- Market Cap
- P/E Ratio
0% Div Yield
210 Volume
- Eps
210 CHF
Previous Close
Day Range
215.5 215.5
Year Range
136.8 223.55
Want to track 0QOC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 35 days

Summary

0QOC closed Friday higher at 215.5 CHF, an increase of 2.62% from Thursday's close, completing a monthly increase of 4.87% or 10 CHF. Over the past 12 months, 0QOC stock gained 18.98%.
0QOC pays dividends to its shareholders, with the most recent payment made on Jul 04, 2025. The next estimated payment will be in In 6 months on Jul 04, 2026 for a total of 7.5 CHF.
The last earnings report, released on Oct 24, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Jan 19, 2026.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on SIX (CHF).

0QOC Chart

HBM Healthcare Investments AG (0QOC) FAQ

What is the stock price today?

The current price is 215.50 CHF.

On which exchange is it traded?

HBM Healthcare Investments AG is listed on SIX.

What is its stock symbol?

The ticker symbol is 0QOC.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, no market cap data is available.

When is the next earnings date?

The next earnings report will release on Jan 19, 2026.

Has HBM Healthcare Investments AG ever had a stock split?

No, there has never been a stock split.

HBM Healthcare Investments AG Profile

Banks Industry
Financials Sector
Dr. Andreas Wicki Ph.D. CEO
LSE Exchange
CH0012627250 ISIN
CH Country
- Employees
2 Jul 2025 Last Dividend
- Last Split
- IPO Date

Overview

HBM Healthcare Investments AG is a seasoned investor in the healthcare industry, focusing on a broad spectrum of investment opportunities within the sector. The company leverages a multifaceted strategy that includes both fund of funds and direct investments, targeting middle market and mature companies as well as emerging and small cap public entities. With an investment philosophy that spans the entire lifecycle of a company—from start-up phases to late-stage ventures and buyouts—HBM Healthcare Investments AG stands out for its dedication to fostering growth within the healthcare sector. The company's investment approach is global, with particular attention to Asia Pacific, Asia, North America, and Europe, underscoring its aim to capitalize on healthcare innovations and advancements worldwide. By actively engaging with its portfolio companies, often taking board positions and participating in follow-on financings or IPOs, HBM Healthcare Investments AG is deeply committed to the success and expansion of its investments.

Products and Services

  • Fund of Funds Investments
  • HBM Healthcare Investments AG invests in venture capital funds as part of its fund of funds strategy, seeking to diversify its investment portfolio and tap into the broader potential within the healthcare sector. This approach allows HBM to access a wide range of healthcare-related ventures indirectly, spreading risks while participating in the growth of various companies.

  • Direct Investments
  • The company is actively engaged in direct investments across different stages of a company's growth, including startup, early, mid, and late stages, as well as in mature companies. This direct involvement ranges from seed funding to support innovative healthcare solutions at their inception to providing growth capital and participating in buyouts and PIPES (Private Investment in Public Equity), accentuating HBM's flexibility and depth in investment strategies.

  • Focus on Healthcare Sector
  • HBM Healthcare Investments AG primarily focuses its investments on the healthcare sector, with a special emphasis on human medicine, drugs, pharma, biopharma, biotechnology, diagnostics, medical technology, and related industries. This targeted approach allows HBM to leverage its extensive knowledge and experience in the healthcare sector, aiming to contribute to significant advancements in medical and health-related fields.

  • Global Investment Approach
  • With a strategic focus on investing globally, particularly in the regions of Asia Pacific, Asia, North America, and Europe, HBM Healthcare Investments AG is dedicated to capturing the best healthcare investment opportunities across the world. This global perspective ensures that HBM can support healthcare innovations and companies based in different geographies, reflecting the universal need for healthcare advancements.

  • Equity Investments and Other Financial Instruments
  • HBM Healthcare Investments AG primarily makes equity investments but also employs a variety of financial instruments to support its portfolio companies. These instruments might include convertible bonds, debt securities, structured products, and derivatives. This flexibility in investment tools underscores HBM's adaptability to different investment scenarios and its commitment to fostering company growth in the most effective manner possible.

  • Exit Strategies
  • The fund actively plans exit strategies for its investments, predominantly through trade sales or IPOs (Initial Public Offerings). By focusing on exit planning as a part of its investment strategy, HBM ensures that there is a clear path to realizing the value of its investments, thereby achieving returns for its investors and stakeholders.

Contact Information

Address: Bundesplatz 1
Phone: 41 43 888 7171